U.S. Stoma/Ostomy Care Market is expected to grow with the CAGR of 5.4% in the forecast period of 2022 to 2029. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/us-stoma-ostomy-care-market

The U.S. stoma/ostomy care market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.

Some major players dealing in the U.S. stoma/ostomy care market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement, business expansion, award and recognition into the market. This helped companies to maximize the sales with enhanced product portfolio.

For instance:

• In August 2019, B. Braun Melsungen AG announced that the company participated in the 7th annual United Ostomy Association of America (UOAA) Conference conducted in Philadelphia, U.S. They showcased their line of ostomy products for the betterment of ostomates, thereby strengthening their position in the U.S. market.   

Coloplast Corp., is the dominating player in the U.S. Stoma/Ostomy Care market. The other key players existing in the market are Coloplast Corp, ConvaTec Inc. and B. Braun Melsungen AG among others.

Coloplast Corp.

Coloplast Corp. founded in the year 1957, headquartered in Humlebaek, Denmark. The company focuses on developing products and services that makes life easier for people with intimate healthcare needs. The company has four business segment ostomy care, continence care, interventional urology and wound & skin care where ostomy care is focused segment. The company has several product categories which are ostomy pouches & accessories, catheters & accessories, wound, interventional urology, product finder, evidence & reimbursement and skin in which ostomy pouches & accessories is the market focused category.

For instance

• In August 2021, Coloplast Corp launched Coloplast SenSura Mio products in the U.S. for extended-wear use. The product was known to provide extended wear with leakage proof to some extent. This helped company in extending its product presence in the U.S. market.

The company has presence across North America, South America, Europe, Middle East and Africa and Asia-Pacific. The subsidiaries of company include, Coloplast de Argentina S.A. (Argentina), Coloplast Pty. Ltd (Australia), Coloplast Belgium S.A. (Belgium), Coloplast do Brasil Ltda (Brazil), Coloplast Canada Corporation (Canada), among others.

ConvaTec Inc.

ConvaTec Inc.  Headquarters is in Deeside, U.K., founded in 1978. The company is focused on helping people with chronic health conditions that lead the life they need by giving them more mobility, confidence and freedom The company has many business segments such as advanced wound care, ostomy care, continence & critical care and infusion care and ostomy care is the market focused segment. The company has several product categories including ostomy, wound & skin, continence & critical care in which ostomy is the market focused category.

For instance,

• In March 2021, ConvaTec Group PLC has made a contract agreement with Vizient Inc., a leading healthcare improvement company. This agreement will allow accessibility of all ConvaTec ostomy products and the me+ support program to Vizient Inc. members. This helped company in enhancing their vision of making the wide reach of their products.   

The company has wide presence across North America, South America, Europe, Middle East and Africa and Asia-Pacific. The company also has various subsidiary companies including ConvaTec Services Limited (U.K.), Cidron Healthcare Limited (Jersey), ConvaTec Healthcare Ireland Limited (Ireland), ConvaTec France Holdings SAS (France), ConvaTec Spain Holdings, S.L. (Spain), and among others.

B. Braun Melsungen AG

B. Braun Melsungen AG headquarter in Melsungen, Germany incorporated in 1839. The company is focused on providing effective treatments along with user friendly products and product systems that are cost effective and will provide opportunities for the market. The company has several product categories which are abdominal surgery, diabetes care, infusion, nutrition, ostomy care, cardio-thoracic surgery, interventional vascular therapy, orthopedic surgery, spine surgery, continence care & urology, extracorporeal blood treatment, sterile goods management, neurosurgery, infection prevention,  iv drugs, regional anesthesia, other products, wound closure in which ostomy care is the market focused category.

For instance,

• In March 2018, B. Braun Melsungen AG announced the launch of the company's new ostomy website called myosto: a new ostomy resource that offers educational information and support. This website allows ostomates to navigate the ostomy care journey by giving each day tips. This enhanced the company's recognition among the ostomy community

The company has presence across Asia-Pacific, Europe, South America, North America and Middle East and Africa. The company has various subsidiaries including Aesculap AG (Germany), B. Braun Medical Supplies., Inc. (Philippines), B. Braun Singapore Pte., Ltd (Singapore), B. Braun Taiwan Co., Ltd, Inc. (Taiwan), and B. Braun Thailand Ltd. (Thailand) among others.